Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lonely At The Top? Not In OTC Sector As Bayer, GSK/Novartis Challenge J&J

This article was originally published in The Tan Sheet

Executive Summary

Bayer closes its acquisition of Merck & Co.’s consumer business, aiming to become the top OTC player and saying other consumer product acquisitions could follow. Glaxo and Novartis look to close their agreement to combine their OTC businesses in the first half of 2015.

Advertisement

Related Content

Taking GSK's Consumer Helm Gives McNamara View From Atop The OTC Space
Taking GSK's Consumer Helm Gives McNamara View From Atop The OTC Space
Sanofi Adds Consumer Brands, Grows Footprint With Boehringer Ingelheim Deal
Sanofi Adds Consumer Brands, Grows Footprint With Boehringer Ingelheim Deal
Bayer, Glaxo Find Steps Difficult Toward Better Margins In Consumer Product Space
Bayer, Glaxo Find Steps Difficult Toward Better Margins In Consumer Product Space
J&J Bullish On OTC Drug Pricing, Consumer Regard For Its Brands
J&J Bullish On OTC Drug Pricing, Consumer Regard For Its Brands
J&J Looks To Expand Consumer Business After Consent Decree Obligations End
FDA Enforces Consent Decree Over J&J/McNeil's OTC Manufacturing

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS107216

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel